D-glucose triggers multidrug resistance-associated protein (MRP)-mediated secretion of fluorescein across rat jejunum in vitro

被引:20
作者
Legen, I [1 ]
Kristl, A [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
active secretion; drug absorption; fluorescein; multidrug resistance-associated protein (MRP); side-by-side diffusion cells;
D O I
10.1023/B:PHAM.0000022410.89709.c3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To examine the transport characteristics of the multidrug resistance - associated protein (MRP) substrate fluorescein across the isolated rat small intestinal segments. Methods. The transport of fluorescein was studied in side-by-side diffusion chambers under short-circuited conditions at physiological pH. Results. The serosal-to-mucosal permeability of fluorescein significantly exceeded the permeability in the opposite direction in the jejunum, but not in the ileum. This asymmetry in transport in the jejunum was observed only when D-glucose was present at the mucosal side of the tissue, and not in the presence of D-galactose or D-mannitol. In the presence of D-glucose at the mucosal side, serosal-to-mucosal permeability of fluorescein in the jejunum can be divided into an active (Michaelis-Menten constant, K-M = 1.07 mM; maximum flux of the substrate, J(max) = 14.0 nmol/h . cm(2)) and a passive component ( passive permeability, P-pas = 2.51 x 10(-6) cm/s). The polarization of fluorescein transport was almost completely abolished by MRP inhibitor, benzbromarone (50 or 100 muM, applied apically), and by MRP/P-glycoprotein inhibitor, verapamil (200 muM, applied apically). Conclusions. D-glucose at the mucosal side activates fluorescein secretion across rat jejunum by an apical MRP, most probably by isoform 2 (MRP2), which could have an impact on the intestinal absorption of MRP substrates.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 30 条
[1]   Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions [J].
Bakos, É ;
Evers, R ;
Sinkó, E ;
Váradi, A ;
Borst, P ;
Sarkadi, B .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :760-768
[2]   Budesonide reduces multidrug resistance-associated protein 1 expression in an airway epithelial cell line (Calu-1) [J].
Bandi, N ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 437 (1-2) :9-17
[3]   THE EFFECT OF FOOD ON THE SYSTEMIC AVAILABILITY OF KETOPROFEN [J].
BANNWARTH, B ;
LAPICQUE, F ;
NETTER, P ;
MONOT, C ;
TAMISIER, JN ;
THOMAS, P ;
ROYER, RJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 (06) :643-645
[4]   Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers [J].
Batrakova, EV ;
Li, S ;
Miller, DW ;
Kabanov, AV .
PHARMACEUTICAL RESEARCH, 1999, 16 (09) :1366-1372
[5]   Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions [J].
Bodó, A ;
Bakos, E ;
Szeri, F ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23529-23537
[6]   Tissue distribution and chemical induction of multiple drug resistance genes in rats [J].
Brady, JM ;
Cherrington, NJ ;
Hartley, DP ;
Buist, SC ;
Li, N ;
Klaassen, CD .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) :838-844
[7]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[8]   STUDIES ON FLUORESCEIN .3. THE ACID STRENGTHS OF FLUORESCEIN AS SHOWN BY POTENTIOMETRIC TITRATION [J].
DIEHL, H ;
HORCHAKMORRIS, N ;
HEFLEY, AJ ;
MUNSON, LF ;
MARKUSZEWSKI, R .
TALANTA, 1986, 33 (11) :901-905
[9]   Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats [J].
Dietrich, CG ;
De Waart, DR ;
Ottenhoff, R ;
Schoots, IG ;
Elferink, RPJO .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :974-980
[10]  
GENUTH SM, 1998, PHYSIOLOGY, P779